| Filing Date | T Date | Ticker | Sector | Ind | Industry | Owner | oSt | Rel | Title | #f | T | TVal | Price | L | Qty | oc | Own | H | r2y | r1y | r6m | r3m | r6w | r3w | r7d | r3d | f1d | f1w | f1m | f3m | f6m | f1y | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9/26/25 16:08 | 9/24/25 | TARS | Health | BioPrd | Biological Products, (No Diag | Azamian Bobak R. | CA | DO | P,CEO,Bo | 2 | S | -632 | 52.69 | 0 | -12 | 872 | I | |||||||||||||||
| 9/16/25 16:06 | 9/15/25 | TARS | Health | BioPrd | Biological Products, (No Diag | Morrison Scott W | CA | D | 1 | M.d | 0 | 0.00 | 0 | 1 | 14 | 11 | D | |||||||||||||||
| 9/10/25 17:03 | 9/8/25 | TARS | Health | BioPrd | Biological Products, (No Diag | Link William J Phd | CA | D | 1 | S | -1,546 | 57.00 | 0 | -27 | 154 | D | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |